about
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product cand...
Read More
13.60
0.32
(2.41%)
27,424
XNAS Volume
XNAS 05 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Nextcure Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..